Immunic, Inc.
(NASDAQ:IMUX)
$1.49
-0.09 (-5.70%)
At Close: 4:00 PM
$1.48
-0.01 (-0.67%)
After Market: 7:25 PM
Immunic Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
Immunic Stock Price Today
Immunic, Inc. (IMUX) stock declined over -5.70% intraday to trade at $1.49 a share on NASDAQ. The stock opened with a loss of 0.00% at $1.58 and touched an intraday high of $1.6, falling -5.70% against the last close of $1.58. The Immunic, Inc. in stock market went to a low of $1.435 during the session.
Immunic Stock Snapshot
$1.58
Prev. Close
70.61 Million
Market Cap
$1.435
Day Low
$1.58
Open
38.31 Million
Number of Shares
$1.6
Day High
-
P/E ratio
-3.63
EPS (TTM)
1.85
Cash Flow per Share
18.08
Free Float in %
7.50
Book Value
590,511
Volume
Contact Details
1200 Avenue of the Americas
Suite 200
New York, NY 10036
United States
Website:https://www.immunic-therapeutics.com
Contact #:332 255 9818
Company Information
Employees66
Beta1.92
Sales or Revenue-
5Y Sales Change-
Fiscal Year EndsDec. 2021
SectorHealth Care
IndustryBiotechnology
About Company
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
Frequently Asked Questions
What is the current Immunic, Inc. (IMUX) stock price?
Immunic, Inc. (NASDAQ: IMUX) stock price is $1.49 in the last trading session. During the trading session, IMUX stock reached the peak price of $1.6 while $1.435 was the lowest point it dropped to. The percentage change in IMUX stock occurred in the recent session was -5.70% while the dollar amount for the price change in IMUX stock was -$0.09.
IMUX's industry and sector of operation?
The NASDAQ listed IMUX is part of Biotechnology industry that operates in the broader Health Care sector. Immunic, Inc. , a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases.
Who are the executives of IMUX?
Dr. Duane D. Nash M.B.A., M.D., J.D., M.B.A
Executive Chairman
Dr. Daniel Vitt
Chief Executive Officer, Pres & Director
Dr. Duane D. Nash M.B.A., M.D., J.D., M.B.A
Exec. Chairman
Dr. Daniel Vitt
CEO, Pres & Director
How IMUX did perform over past 52-week?
IMUX's closing price is 0.34% higher than its 52-week low of $1.11 where as its distance from 52-week high of $12.639 is -0.88%.
How many employees does IMUX have?
Number of IMUX employees currently stands at 66. IMUX operates from 1200 Avenue of the Americas, Suite 200, New York, NY 10036, United States.
Link for IMUX official website?
Official Website of IMUX is: https://www.immunic-therapeutics.com
How do I contact IMUX?
IMUX could be contacted at phone #332 255 9818 and can also be accessed through its website. IMUX operates from 1200 Avenue of the Americas, Suite 200, New York, NY 10036, United States.
How many shares of IMUX are traded daily?
IMUX stock volume for the day was 590,511 shares. The average number of IMUX shares traded daily for last 3 months was 1.03 Million.
What is the market cap of IMUX currently?
The market value of IMUX currently stands at $70.61 Million with its latest stock price at $1.49 and 38.31 Million of its shares outstanding.